QIMA Life Sciences launches SQINGEVITY, bringing biological testing and clinical studies together to examine claims about ...

Better U and Evernow have joined forces to pair menopause specialists with psychiatry in a nationwide telehealth service.

Small open-label study of ATR-258 saw fat loss, lean mass gains and better leg power, but no placebo group and just eight ...

Arvinas presented early biomarker data on ARV-102, an oral drug built to clear the LRRK2 protein, at a major Parkinson’s ...

A two-year partnership with Ultrahuman aims to connect clinical biomarkers and wearable data, bringing aging assessment into ...

GPX4-targeting therapy reduces epigenetic age markers and circulating inflammation, raising questions about effects beyond ...

MUST’s RETRO-EPIGERNA team won $1 million and a place in the $81 million finals, though key trial details remain undisclosed.

Ascensia partnership puts the London healthtech’s microsensor on the road to a European launch – with ambitions that run well ...

A new partnership is combining a blood test, a cognitive app and national infrastructure to cut Britain’s years-long ...

Neither the FDA nor EMA recognizes aging as an indication – but the drafts, the precedent and the people on record are ...

At ARDD 2026, senior FDA officials sketch how a therapy targeting aging might one day reach approval, revealing that ...

Deep Longevity’s new US telehealth platform, Accrua, ties treatment plans to a blood-based aging score and re-tests every ...